Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England.
Irenjeet BainsYoon Hong ChoiKate SoldanMark JitPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
England's move from cytology to HPV screening may potentially be life-saving and cost-effective. Cost-effectiveness can be improved further by extending the interval between screens or using alternative triage methods such as partial or full genotyping.